Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Painter

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
The Journal of Urology|July 2, 1998
Subspecialization, recruitment and retirement trends of American urologistsW F Gee, H L Holtgrewe, P C Albertsen, et al.
Journal of Virology|October 4, 2019
Small-Molecule Antiviral β-d-<i>N</i><sup>4</sup>-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to ResistanceMaria L Agostini, Andrea J Pruijssers, James D Chappell, et al.
Science Translational Medicine|October 25, 2019
Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epitheliaMart Toots, Jeong-Joong Yoon, Robert M Cox, et al.
Journal of Virology|March 21, 2024
Modeling Heartland virus disease in mice and therapeutic intervention with 4'-fluorouridineJonna B Westover, Kie Hoon Jung, Cigdem Alkan, et al.
Science Advances|May 22, 2026
Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus modelsCarolin M Lieber, Josef D Wolf, Mugunthan Govindarajan, et al.
Plos Pathogens|April 17, 2023
4'-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza virusesCarolin M Lieber, Megha Aggarwal, Jeong-Joong Yoon, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus modelsCarolin M Lieber, Josef D Wolf, Mugunthan Govindarajan, et al.
Plos Pathogens|April 3, 2026
Efficacy of the nucleoside analog 4'-Fluorouridine against Nipah virus in the Syrian hamster modelOlivier Escaffre, Madison L Pearson, Terry L Juelich, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial VirusesJeong-Joong Yoon, Mart Toots, Sujin Lee, et al.
European Journal of Medicinal Chemistry|February 25, 2026
Development of a nucleotide prodrug of 4'-fluorouridine to improve tolerabilityAustin T Ryan, Jean-Marc I A Lawrence, Brett Virgin-Downey, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
The Journal of Urology|July 2, 1998
Subspecialization, recruitment and retirement trends of American urologistsW F Gee, H L Holtgrewe, P C Albertsen, et al.
Journal of Virology|October 4, 2019
Small-Molecule Antiviral β-d-<i>N</i><sup>4</sup>-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to ResistanceMaria L Agostini, Andrea J Pruijssers, James D Chappell, et al.
Science Translational Medicine|October 25, 2019
Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epitheliaMart Toots, Jeong-Joong Yoon, Robert M Cox, et al.
Journal of Virology|March 21, 2024
Modeling Heartland virus disease in mice and therapeutic intervention with 4'-fluorouridineJonna B Westover, Kie Hoon Jung, Cigdem Alkan, et al.
Science Advances|May 22, 2026
Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus modelsCarolin M Lieber, Josef D Wolf, Mugunthan Govindarajan, et al.
Plos Pathogens|April 17, 2023
4'-Fluorouridine mitigates lethal infection with pandemic human and highly pathogenic avian influenza virusesCarolin M Lieber, Megha Aggarwal, Jeong-Joong Yoon, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2026
Developmental candidate GHP-88310/EIDD-3608 with high tolerability and oral efficacy in measles and respiratory paramyxovirus modelsCarolin M Lieber, Josef D Wolf, Mugunthan Govindarajan, et al.
Plos Pathogens|April 3, 2026
Efficacy of the nucleoside analog 4'-Fluorouridine against Nipah virus in the Syrian hamster modelOlivier Escaffre, Madison L Pearson, Terry L Juelich, et al.
Antimicrobial Agents and Chemotherapy|June 13, 2018
Orally Efficacious Broad-Spectrum Ribonucleoside Analog Inhibitor of Influenza and Respiratory Syncytial VirusesJeong-Joong Yoon, Mart Toots, Sujin Lee, et al.
European Journal of Medicinal Chemistry|February 25, 2026
Development of a nucleotide prodrug of 4'-fluorouridine to improve tolerabilityAustin T Ryan, Jean-Marc I A Lawrence, Brett Virgin-Downey, et al.
Pageof 19